The influence of three L-type calcium channel blockers on morphine effects in healthy volunteers

Anesthesia and Analgesia

Volumn 85, Issue 3, 1997, Pages 633-638

  Hasegawa, Amy E ^a   Zacny, James P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; MORPHINE; NIMODIPINE; VERAPAMIL;

ADULT; ANESTHESIA; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL;

ADJUVANTS, ANESTHESIA; ADULT; AFFECT; ANALGESICS, OPIOID; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DILTIAZEM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MORPHINE; NIMODIPINE; PAIN THRESHOLD; PSYCHOMOTOR PERFORMANCE; REFERENCE VALUES; VERAPAMIL;

EID: 0030846226     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199709000-00026     Document Type: Article

References (29)

1. Pucilowski O. Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology 1992;109:12-29.
2. Carta F, Bianchi M, Argenton S, et al. Effect of nifedipine on morphine-induced analgesia. Anesth Analg 1990;70:493-8.
3. Contreras E, Tamayo L, Amigo M. Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. Eur J Pharmacol 1988;148:463-6.
4. Benedek G, Szikszay M. Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. Pharmacol Res Commun 1984;16:1009-18.
5. Kuzmin A, Patkina N, Pchelintsev M, Zvartau E. Isradipine is able to separate morphine-induced analgesia and place conditioning. Brain Res 1992;593:221-5.
6. Omote K, Sonoda H, Kawamata M, et al. Potentiation of antinociceptive effects of morphine by calcium channel blockers at the level of the spinal cord. Anesthesiology 1993;79:746-52.
7. Spampinato S, Speroni E, Govoni P, et al. Effect of ω-conotoxin and verapamil on antinociceptive, behavioural and thermoregulatory responses to opioids in the rat. Eur J Pharmacol 1994; 254:229-38.
8. Filos KS, Goudas LC, Patroni O, Tassoudis V. Analgesia with epidural nimodipine [letter]. Lancet 1993;342:1047.
9. Filos KS, Dodou V, Patroni O, et al. Perioperative nimodipine reduces the requirements for anaesthetics and for intra-and postoperative analgesics [abstract]. Br J Anaesth 1996;76:123.
10. Santillán R, Maestre JM, Hurlé MA, Flórez J. Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary report. Pain 1994;58: 129-32.
11. Vaupel DB, Lange WR, London ED. Effects of verapamil on morphine-induced euphoria, analgesia and respiratory depression in humans. J Pharmacol Exp Ther 1993;267:1386-94.
12. Cleeland CS, Nakamura Y, Howland EW, et al. Effects of oral morphine on cold pressor tolerance time and neuropsychological performance. Neuropsychopharmacology 1996;15:252-62.
13. Abbott FV, Etienne P, Franklin KBJ, et al. Acute trytophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 1992;108:60-6.
14. Derogatis LR, Lipman RS, Covi L. HSCL-90: an outpatient psychiatric rating scale - a preliminary report. Psychopharmacol Bull 1973;9:13-7.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd rev. ed. Washington, DC: American Psychiatric Association, 1987.
16. Murad F. Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers, and beta-adrenergic antagonists. In: Gilman AG, Rail T, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990:764-83.
17. Physicians' desk reference, 49th ed. Montvale, NJ: Medical Economics Data Production, 1995.
18. Chen ACN, Dworkin SF, Haug J. Human pain responsivity in a tonic pain model: physiological determinants. Pain 1989;37: 143-60.
19. Haertzen CA. Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol Rep 1966;18:163-94.
20. Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971;12:245-58.
21. Fraser HF, van Horn GG, Martin WR, et al. Methods for evaluating abuse liability. (A) "Attitude" of opiate addicts towards opiate-like drugs. (B) A short-term "direct" addiction test. J Pharmacol Exp Ther 1961;133:371-87.
22. Preston KL, Bigelow GE, Bickel WK, Liebson IA. Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther 1989;250:184-96.
23. Strain EC, Preston KL, Liebson IA, Bigelow GE. Precipitated withdrawal by pentazocine in methadone-maintained volunteers. J Pharmacol Exp Ther 1993; 267:624-34.
24. Manner T, Kanto J, Salonen M. Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers. Eur J Clin Pharmacol 1987;31:673-6.
25. Zacny JP, Lichtor JL, Flemming D, et al. A dose-response analysis of the subjective, psychomotor, and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther 1994;268:1-9.
26. Hannington-Kiff JG. Measurement of recovery from outpatient general anaesthesia with a simple ocular test. BMJ 1970;3:132-5.
27. Blom MW, Bartel PR, Sommers DK, et al. The comparison of the effects of multi and single doses of buspirone, chlordiazepoxide, and hydroxyzine on psychomotor function and EEG. Fund Clin Pharmacol 1992;6:5-9.
28. Omote K, Kawamata M, Satoh O, et al. Spinal antinociceptive action of an N-type voltage-dependent calcium channel blocker and the synergistic interaction with morphine. J Pharmacol Exp Ther 1996;184:636-43.
29. Bowersox SS, Gadbois T, Singh T, et al. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther 1996;279:1243-9.